Skip to content

study to see the effect of oral pregabalin if given before laparoscopic cholecystectomy surgery on pain occurring after surgery and the need for additional analgesic

Effect of preoperative administration of oral pregabalin on post-operative pain intensity and analgesic requirement following laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053222
Enrollment
60
Registered
2023-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis Health Condition 2: K802- Calculus of gallbladder without cholecystitis

Interventions

Intervention1: Pregabalin: dose: 150 mg frequency: once before surgery route: oral Control Intervention1: placebo: dose: 150 mg frequency: once before surgery route: oral

Sponsors

Mahatma Gandhi Medical College Hospital Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.American Society of Anesthesiologists (ASA) I and II patients. 2.Age group of 18-65 years. 3.Patient with written valid consent. 4.Patient undergoing elective laparoscopic cholecystectomy.

Exclusion criteria

Exclusion criteria: 1.Patient refusal to participate in study. 2.History of allergy to study drug. 3.Pregnant and Lactating women. 4.Patient with impaired liver or kidney function. 5.History of chronic pain or daily intake of analgesics. • History of chronic use of central nervous system depressant drugs and anti-convulsant. • Morbidly obese. • Inability to comprehend or participate in pain scoring system.

Design outcomes

Primary

MeasureTime frame
To assess the post operative pain intensity at rest and on movement. To assess total dose of rescue analgesia required in first 24 hoursTimepoint: 0 hour 8 hour 16 hour 24 hour

Secondary

MeasureTime frame
to assess severity and side effects of drugTimepoint: post operatively

Countries

India

Contacts

Public ContactDr Ganesh R Nimje

Mahatma Gandhi Medical College

ganesh.nimje8@gmail.com9503332784

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026